Vilanterol trifenatato, Fluticasone

Relvar Ellipta 92 Microgramos/22 Microgramospolvo Para Inhalacion (Unidosis)

25 µg + 100 µg polvo para inhalación (unidosis)SpainMarketedAuthorised 12 Mar 2019

In other countries

The same active substances on other registers, the same brand first.

Relvar ElliptaBrazil · Glaxosmithkline Brasil LtdaSame brand
Relvar ElliptaCroatiaSame brand
Relvar ElliptaItaly · Polvere per inalazione, pre-dosata · Glaxosmithkline Trading Services LimitedSame brand
RELVAR ELLIPTA 200/25 mcg inhalation powderSaudi Arabia · Glaxo OperationSame brand
RELVAR ELLIPTA inhalation powderSaudi Arabia · Glaxo OperationSame brand
Relvar Ellipta Inhalation Powder 100MCG/25MCGSingapore · 100 mcg/dose + 25 mcg/dose · powder, metered · Glaxosmithkline Pte LTDSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vilanterol trifenatato, Fluticasone

Relvar Ellipta 92 Microgramos/22 Microgramospolvo Para Inhalacion (Unidosis)

25 µg + 100 µg polvo para inhalación (unidosis)SpainMarketedAuthorised 12 Mar 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Relvar Ellipta Inhalation Powder 200MCG/25MCG

Singapore · 200 mcg/dose + 25 mcg/dose · powder, metered · Glaxosmithkline Pte LTD

Revinty ElliptaCroatia

Revinty ElliptaItaly · Polvere per inalazione, pre-dosata · Glaxosmithkline Trading Services Limited

Breo ElliptaUnited States · 0.05MG/INH; 0.025MG BASE/INH, 0.1MG/INH; 0.025MG BASE/INH, 0.2MG/INH; 0.025MG BASE/INH · powder · Glaxo GRP LTD

Packs

Pack	Code	Status
RELVAR ELLIPTA 92 MICROGRAMOS/22 MICROGRAMOSPOLVO PARA INHALACION (UNIDOSIS), 30 dosis	725109

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Vilanterol trifenatato, Fluticasone
Strength: 25 µg + 100 µg
Dosage form: polvo para inhalación (unidosis)
Route: vía inhalatoria
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 12 Mar 2019
Registration: 13886002IP1
Marketing authorisation holder: Glaxosmithkline (Ireland) Limited
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

Vilanterol trifenatato + Fluticasone · 25 µg + 100 µg · polvo para inhalación (unidosis)

Spain

Relvar Ellipta 92 MCG/22 MCG Polvo Para Inhalacion (Unidodis)Vilanterol trifenatato + Fluticasone · 25 µg + 100 µg · polvo para inhalación (unidosis)Spain

Relvar Ellipta 92 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)Vilanterol trifenatato + Fluticasone · 25 µg + 100 µg · polvo para inhalación (unidosis)Spain

RELVAR ELLIPTA 92mcg/22mcg polvo para inhalacion (unidosis)Vilanterol trifenatato + Fluticasone · 25 µg + 100 µg · polvo para inhalación (unidosis)Spain